Riskpilot← Back to searchSign inGet full accessIMEDICI AB
ABActiveOrg 5567412274Gråbrödersgatan 8Hospital activities · NACE 8610Est. 20071-4 employees
Revenue 2024
SEK 2,4M
-20% vs 2023
EBITDA margin
4.3%
-85% vs 2023
Equity ratio
28.6%
Financial strength
Net profit 2024
SEK 65K
-87% vs 2023
| Revenue | SEK 2,4M | -20% |
| EBITDA | SEK 104K | -85% |
| Net profit | SEK 65K | -87% |
| Total assets | SEK 3M | +9% |
| Equity | SEK 850K | -15% |
| Employees | — | — |
Legal name
IMEDICI AB
Org number
5567412274
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
30 oktober 2007
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva allmän- och specialistverksamhet inom medicin, hälsofrämjande och sjukdomsförebyggande verksamhet. Författande och utgivning av medicinsk och vetenskaplig litteratur. Förvaltning av värdepapper och fast egendom samt därmed förenlig verksamhet. Plastikkirurgisk bedömning, rådgivning och behandling.
Address
Gråbrödersgatan 8
Phone
+46705467718
Email
info@dermagi.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | 1 923 | 2 738 | 3 026 | 2 415 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 0 | −60 | 849 | 673 | 104 |
| Depreciation & amort. | — | −0 | −5 | −25 | −25 |
| EBIT | 0 | −60 | 844 | 648 | 79 |
| Net financials | — | 209 | −1 | 12 | 6 |
| Profit before tax | 0 | 249 | 637 | 660 | 85 |
| Tax | — | −156 | −134 | −140 | −20 |
| Net profit | — | 93 | 503 | 520 | 65 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | — | 1 732 | 2 375 | 2 726 | 2 967 |
| Equity | — | 358 | 681 | 1 000 | 850 |
| Long-term debt | — | 0 | 0 | 0 | 0 |
| Short-term debt | — | 645 | 759 | 789 | 1 180 |
| Total debt | — | 645 | 759 | 789 | 1 180 |
EBITDA margin
4.3%
This company
15.8%
Market median
-73% vs market
20202024
Equity ratio
28.6%
This company
38.2%
Market median
-25% vs market
20202024
Return on equity
7.6%
This company
18.4%
Market median
-59% vs market
20202024
Net profit margin
2.7%
This company
8.1%
Market median
-67% vs market
20202024
Asset turnover
0.81×
This company
1.12×
Market median
+28% vs market
20202024
Debt / equity
2.49×
This company
0.62×
Market median
-302% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CF Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of IMEDICI AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carolin Freccero | Chief Executive Officer | 0 companies |
| Carl Oskar Pippolino Freccero | Deputy Board Member | 0 companies |
| Stefan Natale Freccero | Chairman | 0 companies |